Absorption, Metabolism and Excretion of [14C]Mirabegron (YM178), a Potent and Selective β3-Adrenoceptor Agonist, after Oral Administration to Healthy Male Volunteers-Reference-Cited by-同舟云学术

Absorption, Metabolism and Excretion of [14C]Mirabegron (YM178), a Potent and Selective β3-Adrenoceptor Agonist, after Oral Administration to Healthy Male Volunteers

Published:2012-01-23 Issue:4 Volume:40 Page:815-824
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Takusagawa Shin,van Lier Jan Jaap,Suzuki Katsuhiro,Nagata Masanori,Meijer John,Krauwinkel Walter,Schaddelee Marloes,Sekiguchi Mitsuhiro,Miyashita Aiji,Iwatsubo Takafumi,van Gelderen Marcel,Usui Takashi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference16 articles.

1. Dose-ranging study of once-daily mirabegron (YM178), a novel selective β3-adrenoceptor agonist, in patients with overactive bladder (OAB);Chapple;Eur Urol Suppl,2010

2. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles;Charman;J Clin Pharmacol,1993

3. Site-dependent small intestinal absorption of ranitidine;Gramatté;Eur J Clin Pharmacol,1994

4. The efficacy and tolerability of mirabegron in patients with overactive bladder—results from a European–Australian Phase III trial;Khullar;Eur Urol Suppl,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing silodosin and mirabegron as medical expulsive therapy for distal ureteral calculus: a prospective, randomised study;Central European Journal of Urology;2024

2. Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice;Pharmaceutics;2023-09-04

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Drug Treatment;Handbook of Neurourology;2023

5. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023